Maharashtra Health Minister Prakash Abitkar reviews preparedness ahead of Pandharpur Wari pilgrimage
This year, the Sant Tukaram Maharaj Palkhi will begin its journey from Dehu on June 18, Wednesday, followed by the Sant Dnyaneshwar Maharaj Palkhi from Alandi on June 19, Thursday. The spiritual procession is dedicated to Lord Vitthal and will conclude in Pandharpur on Ashadi Ekadashi, which falls on July 6.
The pilgrimage spans around 20 days and covers nearly 250 km, with daily halts in towns and villages along the route. Throughout the journey, warkaris chant devotional songs and hymns.
In view of the large gatherings anticipated and the surge in COVID-19 cases, state health officials have intensified preparedness measures. While most recent COVID-19 cases have been mild, authorities have advised individuals with co-morbidities to wear masks and take necessary precautions to ensure a safe and incident-free pilgrimage.
State officials said there will be small dispensaries (Aapla Dawakhana) every 5 km along the route and 331 ambulances that will be on call 24×7 (dial 108 or 102), besides identifying 45 intensive care units in case of emergencies. Around 1,300 healthcare personnel will also be deputed for the purpose, including 138 specialists and 149 medical officers. Around 437 nurses will provide care as part of the measures.
'There are cases of dysentery, diarrhoea, fever, and even heart-related issues, so we must remain extremely vigilant,' said a senior health official. Officials at the Food and Drug Administration (FDA) also emphasised that ensuring safe and hygienic conditions is a priority. 'There are numerous food stalls and hotels along the route serving devotees. It is crucial that the food provided is unadulterated,' they said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
28 minutes ago
- New Indian Express
Karnataka CM Siddaramiah's claims on Covid vaccine factually wrong, says Biocon founder
BENGALURU: Refuting Chief Minister Siddaramaiah's remark that the Covid-19 vaccine might be a reason for a sudden spike in heart attack-related deaths, Biocon founder Kiran Mazumdar-Shaw on Wednesday said that the vaccines were approved under the 'Emergency Use Authorisation' framework, adding that the CM was factually incorrect, contributing to public misinformation. On July 1, Siddaramaiah had claimed that it cannot be denied that the hasty approval and distribution of the Covid-19 vaccine to the public could also be a reason for heart attack deaths. Immediately, the Union Health Ministry took objection to his statement, and dismissed the Covid vaccine link with heart attack deaths. 'Covid-19 vaccines developed in India were approved under the Emergency Use Authorisation framework, following rigorous protocols aligned with global standards for safety and efficacy,' Kiran said on Wednesday, in her reply to the CM's X post. 'To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation,' the Biocon founder stated. She further went on to say that these vaccines have saved millions of lives and, like all vaccines, may cause side effects in a very small number of individuals. 'It is important to acknowledge the science and data-driven processes behind their development, rather than engage in retrospective blame,' she ended.
Indian Express
2 hours ago
- Indian Express
Vaccine manufacturers' body, Serum Institute of India reaffirm COVID-19 vaccine safety
The Indian Vaccine Manufacturers Association (IVMA) has assured that all COVID-19 vaccines in India were approved for emergency use authorisation based on extensive evaluation in preclinical studies and human clinical trials. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' Dr G V J A Harshavardhan, Director General, IVMA, said in a statement released on Thursday. The statement sought to reassure the public on the safety and efficacy of COVID-19 vaccines. 'All COVID-19 vaccines in India were approved for emergency use authorisation [restricted use in emergency situations as per World Health Organization guidelines], he said, adding, 'These approvals were based on extensive evaluation in preclinical studies and human clinical trials, with positive results on safety, efficacy, and immunogenicity of these vaccines.' The IVMA statement comes in the backdrop of the Union health ministry saying on Wednesday that extensive studies by several agencies have 'conclusively established no linkages' between COVID-19 vaccines and sudden deaths. The Serum Institute of India also posted on X that the COVID-19 vaccines were safe and scientifically validated. 'Two large-scale studies by ICMR [Indian Council of Medical Research] and AIIMS [All India Institute of Medical Sciences], as cited by the Ministry of Health have found no link between Covid-19 vaccines and sudden deaths,' SII said. The IVMA statement also noted that prior to their release, all COVID-19 vaccines were tested extensively for safety by the manufacturers and were also provided Batch Release Certification by the Central Drugs Laboratory in Kasauli, Himachal Pradesh, under the Ministry of Health and Family Welfare. 'The strengths of innovation and large-scale, high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem. COVID-19 vaccines manufactured in India were largely responsible for not only controlling the COVID-19 pandemic and restricting its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally,' Dr Harshavardhan said. 'This positive impact of COVID-19 vaccination was not only limited to India, but also to several countries worldwide, under the Government of India's Vaccine Maitri programme…,' he added.
Time of India
5 hours ago
- Time of India
Hassan heart attack death cases: India's top drugmakers rally behind Covid vaccines
Leading drugmakers on Thursday rallied in support of Covid vaccines , using various social media platforms, amid a series of deaths in Karnataka's Hassan district due to heart attacks. Dilip Shanghvi, chairman and managing director at Sun Pharmaceuticals said in a post on LinkedIn, 'The deaths of multiple young individuals in one district of Karnataka due to cardiac ailments are unfortunate. While this appears to be specific to the district, linking it to the Covid-19 vaccine without any scientific evidence is "incorrect and misleading". "India's vaccine approval process is rigorous and science-driven, and we must continue to have confidence in it. The vaccine has been administered to millions across the country. If there were a connection, we would have seen similar incidents in many other places — which is not the case. The State health authorities should thoroughly investigate the situation to determine the cause,' Sanghavi said. Sorting to allay the apprehensions, Pankaj Patel, chairman, Zydus Lifesciences , which also manufactures Covid DNA vaccine, said in a post on X, 'There are other multiple reasons like age, environmental factors, genetics, lifestyle etc, that could be the leading cause of heart attacks in people. Several scientific studies globally and in India have conclusively shown that the risk of heart attack or myocarditis is greater after SARS-CoV-2 infection. #Vaccines save lives.' Appreciating the vaccination programme, Patel said, "the massive vaccination programme in our country during the peak of Covid phase saved millions of people and families. In fact a study published in Lancet estimated that India averted almost 3.4 million deaths due to vaccination in the year 2021," he said. Live Events Satish Reddy, chairman, Dr Reddy's Laboratories, wrote, 'India-made vaccines are by WHO and used worldwide. They helped end polio and fight Covid. At a time when India is seen as a vaccine leader, let's build trust in science, not doubt it. Public health must stay above politics.' A post on X attributed to Samir Mehta, executive chairman, Torrent Pharma said, 'India has earned global recognition as the Pharmacy of the World, supplying safe and effective vaccines to over 90 countries…Let's not allow misinformation to erode trust in science or the integrity of India's healthcare ecosystem.' Responding to rising concerns over the sudden deaths of more than 20 people in Hassan district, the Karnataka health department formed an expert committee to probe a possible link to Covid vaccines. However, support came pouring in for Covid vaccines. The Indian Vaccine Manufacturers Association said Covid-19 vaccines were developed and manufactured in the country with the highest safety and quality standards. Assuring about the safety of these vaccines, Dr/ G.V.J.A. Harshavardhan, director general at the association said the approvals were based on extensive evaluation in preclinical studies and human clinical trials with positive results on safety, efficacy, and immunogenicity of the vaccines. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' he said in a statement. He said prior to releasing the vaccines, they were tested extensively for safety by the manufacturers and are also provided batch release certification by the Central Drugs Laboratory (CDL) of the Ministry of Health and Family Welfare. Sudarshan Jain, secretary general, Indian Pharmaceutical Alliance (IPA) said during the pandemic, vaccines played a crucial role, and India consistently supplied medicines and vaccines across the world. "These vaccines have been well documented and rigorously tested as per regulatory processes. Misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally".
